跳至主要内容
临床试验/NCT02791360
NCT02791360已完成不适用

Evaluation of Anatomy, Clinical and Neuropsychological Long-term Sequelae of Patients Treated With Radiation Therapy for Brain Tumor

Centre Francois Baclesse2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2016年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15
试验地点
2
主要终点
Proportion of patient with MRI abnormality

研究概览

简要总结

Through this study, the investigators believe to describe more accurately the damage caused by brain radiation therapy in the long term.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • In the case group:
  • A history of solid brain tumor or haematological histologically proven.
  • Patients previously treated with radiotherapy in this brain tumor (greater than or equal to 36 Gy dose).
  • Radiotherapy treatment on a tumor in place or operated.
  • Decline at least 10 years from the end of radiotherapy.
  • Treatment with isocentric conformal radiotherapy.
  • No other radiation therapy for locally recurrent brain metastases or new brain tumor.
  • Lack of known brain metastases or meningeal carcinomatosis.
  • For the control group:
  • Patients previously treated for cancer and disease relapse free for 10 years.
  • No brain radiotherapy treatment.
  • Lack of treatment with anti-cancer chemotherapy.
  • Women of childbearing potential must be under effective contraception.
  • Pairing according to age, sex, arms director and socio-cultural level.
  • For two groups:
  • Man or woman aged (e) of minimum 18 years.
  • Topic fluent French and comprising well.
  • Free and Informed Consent signed.
  • The subject should be affiliated to an appropriate social security system
  • No cons-indication to MRI.
  • The subject must have at least one primary school level

排除标准

  • In the case group:
  • Brain radiotherapy carried out by intensity modulation technique.
  • Radiation dose less than 36 Gy on the brain.
  • Subject with against-indication to MRI.
  • For the control group:
  • Previous history of brain radiotherapy.
  • Previous history of brain surgery.
  • Central neurological disorders, such as seizures, uncontrolled.
  • For two groups:
  • Current Topics in oral chemotherapy or intravenous.
  • Subject pregnant.
  • Subject is not fluent in French or including bad.
  • Any geographical conditions, social or associated psychopathology that could compromise the patient's ability to participate in the study.
  • Participation in a therapeutic trial for less than 30 days.
  • A person not affiliated with a social security scheme.

研究组 & 干预措施

MRI evaluation

Other

Patient pretreated for brain tumor and witness

干预措施: Brain MRI (Other)

结局指标

主要结局

Proportion of patient with MRI abnormality

时间窗: up to 4 weeks

To evaluate the proportion of patients with at least one abnormality on an imaging test

次要结局

  • MRI diffusion abnormality(up to 4 weeks)
  • MRI perfusion abnormality(up to 4 weeks)
  • MRI vascular morphologic abnormalities(up to 4 weeks)

研究者

发起方
Centre Francois Baclesse
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验